Dr. Liu leads the Digital Medicine Lab, focusing on ethical and responsible AI for healthcare, with applications in various clinical domains. His research has been funded by the National Medical Research Council (NMRC), National Research Foundation (NRF), National Health Innovation Centre (NHIC), Ministry of Education (MOE), AI Singapore, Duke-NUS Medical School, SingHealth Foundation, and industrial partners such as Continental AG.
Dr. Liu was named among the World’s Top 2% Scientists by Stanford University and Elsevier. He has served as an Editor for more than 10 prestigious peer-reviewed journals, including npj Digital Medicine, PLOS Medicine, BMC Medicine, and IEEE Journal of Biomedical and Health Informatics. Additionally, he is a regular reviewer for many international journals such as The Lancet, JAMA, and Nature Medicine. He also serves on the program committees of several leading AI and data science conferences, including AAAI, NeurIPS, and AMIA.
他领导的数字医学实验室专注于医疗保健和医学研究、临床领域中合乎伦理且值得信赖的人工智能应用。其研究获得新加坡国家医学研究理事会（NMRC）、国家研究基金会（NRF）、国立卫生创新中心（NHIC）、教育部（MOE）、AI Singapore、杜克-新加坡国立大学医学院、新加坡保健集团基金会（SingHealth Foundation）及德国大陆集团（Continental AG）等多家机构和产业界伙伴资助。
柳博士被斯坦福大学和爱思唯尔评为全球前2%顶尖科学家，担任超过10家知名同行评议期刊（如《NPJ数字医学》《PLOS医学》《BMC医学》《IEEE生物医学与健康信息学杂志》）的编辑，并为《柳叶刀》《美国医学会杂志（JAMA）》《自然·医学》等国际权威期刊担任常任审稿人。他亦是多个人工智能及数据科学顶级会议（如AAAI、NeurIPS和AMIA）程序委员会成员。